SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: Pseudo Biologist who wrote (467)12/10/1999 12:25:00 AM
From: sim1  Respond to of 3044
 
>>BTW, what got into Entremed today? Heard any juicy rumors?<<

An (unlikely) explanation from ENMD related news.

siliconinvestor.com

...The market maker saw no solid news behind the options activity and the rise in the stock, which rallied 7-3/16 to 31-3/16 on Nasdaq market volume of 958,000.

Mary Sundeen, a spokesman for Maryland-based EntreMed, said the increase in stock activity recently might be related to higher sales of thalidomide, which EntreMed licensed to Celgene Corp. (NASDAQ: CELG). in December 1998.



To: Pseudo Biologist who wrote (467)12/10/1999 12:32:00 AM
From: scaram(o)uche  Respond to of 3044
 
plus 32%, huh? wow. hadn't noticed.... single parent and Xmas is two weeks away. Entremed? What's an Entremed?